Boris B. Vargaftig
#157,638
Most Influential Person Now
Boris B. Vargaftig's AcademicInfluence.com Rankings
Boris B. Vargaftigmedical Degrees
Medical
#3111
World Rank
#3566
Historical Rank
Pharmacology
#369
World Rank
#420
Historical Rank
Download Badge
Medical
Why Is Boris B. Vargaftig Influential?
(Suggest an Edit or Addition)Boris B. Vargaftig's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Platelet-activating factor induces a platelet-dependent bronchoconstriction unrelated to the formation of prostaglandin derivatives. (1980) (408)
- The role of platelet-activating factor in platelet aggregation (1979) (398)
- BACKGROUND AND PRESENT STATUS OF RESEARCH ON PLATELET‐ACTIVATING FACTOR (PAF‐ACETHER) (1981) (306)
- Interleukin-10 inhibits antigen-induced cellular recruitment into the airways of sensitized mice. (1995) (303)
- Requirement for γδ T Cells in Allergic Airway Inflammation (1998) (267)
- Present concepts on the mechanisms of platelet aggregation. (1981) (242)
- Selective inhibition by mepacrine of the release of “rabbit aorta contracting substance” evoked by the administration of bradykinin (1972) (236)
- Murine models of asthma (2003) (213)
- Platelet activation—a role for a 40K anti-phospholipase A2 protein indistinguishable from lipocortin (1986) (201)
- Eosinophil recruitment into the respiratory epithelium following antigenic challenge in hyper-IgE mice is accompanied by interleukin 5-dependent bronchial hyperresponsiveness. (1995) (200)
- Eosinophil recruitment into guinea pig lungs after PAF-acether and allergen administration. Modulation by prostacyclin, platelet depletion, and selective antagonists. (1988) (199)
- Platelet‐Activating Factor (PAF‐Acether) Secretion from Platelets: Effect of Aggregating Agents (1980) (174)
- Generation of lyso-phospholipids from surfactant in acute lung injury is mediated by type-II phospholipase A2 and inhibited by a direct surfactant protein A-phospholipase A2 protein interaction. (1998) (172)
- Antibody to very late activation antigen 4 prevents antigen-induced bronchial hyperreactivity and cellular infiltration in the guinea pig airways (1994) (167)
- ACCUMULATION OF EOSINOPHILS IN RESPONSE TO INTRACUTANEOUS PAF-ACETHER AND ALLERGENS IN MAN (1986) (142)
- Suppression of asthma-like responses in different mouse strains by oral tolerance. (2001) (141)
- Biosynthesis of platelet-activating factor (PAF-ACETHER). II. Involvement of phospholipase A2 in the formation of PAF-ACETHER and lyso-PAF-ACETHER from rabbit platelets. (1982) (129)
- The platelet‐independent release of thromboxane A2 by Paf‐acether from guinea‐pig lungs involves mechanisms distinct from those for leukotriene (1984) (120)
- Dendritic cells recruited to the lung shortly after intranasal delivery of Mycobacterium bovis BCG drive the primary immune response towards a type 1 cytokine production (2003) (119)
- Endotoxin induces expression of type II phospholipase A2 in macrophages during acute lung injury in guinea pigs: involvement of TNF-alpha in lipopolysaccharide-induced type II phospholipase A2 synthesis. (1997) (111)
- Effect of cyclo‐oxygenase inhibitors and modulators of cyclic AMP formation on lipopolysaccharide‐induced neutrophil infiltration in mouse lung (1996) (109)
- Release of vasoactive substances from guinea-pig lungs by slow-reacting substance c and arachidonic acid. Its blockade by nonsteroid anti-inflammatory agents. (1971) (108)
- Characterization of murine lung inflammation after infection with parental Bordetella pertussis and mutants deficient in adhesins or toxins (1994) (104)
- Systemic administration of endotoxin induces bronchopulmonary hyperreactivity dissociated from TNF-alpha formation and neutrophil sequestration into the murine lungs. (1998) (102)
- Platelet-activating factor today (1983) (101)
- Ultrastructural evidence for extravascular platelet recruitment in the lung upon intravenous injection of platelet-activating factor (PAF-acether) to guinea-pigs. (1985) (101)
- Requirement for gammadelta T cells in allergic airway inflammation. (1998) (97)
- In vivo neutralization of eosinophil-derived major basic protein inhibits antigen-induced bronchial hyperreactivity in sensitized guinea pigs. (1996) (94)
- INVOLVEMENT OF PLATELET ACTIVATING FACTOR IN RESPIRATORY ANAPHYLAXIS, DEMONSTRATED BY PAF-ACETHER INHIBITOR BN 52021 (1985) (85)
- Airway administration of Escherichia coli endotoxin to mice induces glucocorticosteroid-resistant bronchoconstriction and vasopermeation. (2001) (81)
- Effect of antigen provocation of IL-5 transgenic mice on eosinophil mobilization and bronchial hyperresponsiveness. (1996) (76)
- Platelets mediate the action of diethylcarbamazine on microfilariae (1987) (76)
- Endotoxins, asthma, and allergic immune responses. (2000) (75)
- Selective Mycobacterium avium–induced production of nitric oxide by human monocyte‐derived macrophages (1994) (71)
- Interference by the novel PAF-acether antagonist WEB 2086 with the bronchopulmonary responses to PAF-acether and to active and passive anaphylactic shock in guinea-pigs. (1987) (71)
- Human platelets stimulated by thrombin produce platelet-activating factor (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) when the degrading enzyme acetyl hydrolase is blocked. (1985) (68)
- A genome-wide screen for asthma-associated quantitative trait loci in a mouse model of allergic asthma. (1999) (65)
- Activation of guinea-pig platelets induced by convulxin, a substance extracted from the venom of Crotalus durissus cascavella. (1980) (65)
- CHAPTER 18 – Platelet-Activating Factor: An Ether Lipid with Biological Activity (1983) (65)
- Role of eosinophil activation in the bronchial reactivity of allergic guinea pigs. (1994) (63)
- Effects of Mycobacterium bovis BCG on the development of allergic inflammation and bronchial hyperresponsiveness in hyper-IgE BP2 mice vaccinated as newborns. (2001) (63)
- Non-steroidal anti-inflammatory drugs if combined with anti-histamine and anti-serotonin agents interfere with the bronchial and platelet effects of "platelet-activating factor" (PAF-acether). (1982) (59)
- Dog platelets fail to aggregate when they form aggregating substances upon stimulation with arachidonic acid. (1976) (58)
- Evidence for cAMP-dependent Platelet Ectoprotein Kinase Activity That Phosphorylates Platelet Glycoprotein IV (CD36)* (1996) (58)
- Increased synthesis and secretion of a 14-kDa phospholipase A2 by guinea pig alveolar macrophages. Dissociation from arachidonic acid liberation and modulation by dexamethasone. (1993) (57)
- Active immunization induces lung hyperresponsiveness in the guinea pig. Pharmacologic modulation and triggering role of the booster injection. (1988) (56)
- Activation of guinea pig eosinophils by human recombinant IL-5. Selective priming to platelet-activating factor-acether and interference of its antagonists. (1991) (56)
- Blockade by fenspiride of endotoxin-induced neutrophil migration in the rat. (1993) (53)
- Elicitation of the allergic reaction in β‐lactoglobulin‐sensitized Balb/c mice: biochemical and clinical manifestations differ according to the structure of the allergen used for challenge (2003) (53)
- Pharmacological modulation of Paf‐induced rat pleurisy and its role in inflammation by zymosan (1989) (52)
- 1-O-alkyl-2-acyl-sn-glycero-3-phosphorylcholine is the precursor of platelet-activating factor in stimulated rabbit platelets. Evidence for an alkylacetyl-glycerophosphorylcholine cycle. (1985) (52)
- Inhibition by aspirin of bronchoconstriction due to leukotrienes C4 and D4 in the guinea pig. (1981) (51)
- One, two, three or more pathways for platelet aggregation. (2009) (51)
- Inhibition by sulfhydryl agents of arachidonic acid-induced platelet aggregation and release of potential inflammatory substances. (1974) (51)
- Blockade by metal complexing agents and by catalase of the effects of arachidonic acid on platelets: relevance to the study of anti-inflammatory mechanisms. (1975) (50)
- Adrenaline and PAF-acether synergize to trigger cyclooxygenase-independent activation of plasma-free human platelets. (1982) (50)
- Mucous-cell metaplasia and inflammatory-cell recruitment are dissociated in allergic mice after antibody- and drug-dependent cell depletion in a murine model of asthma. (1999) (49)
- From lung hypersensitivity to bronchial hyperreactivity. What can we learn from studies on animal models? (1993) (47)
- Secretory phospholipase A2 is not required for arachidonic acid liberation during platelet activation. (1993) (47)
- Platelet secretory phospholipase A2 fails to induce rabbit platelet activation and to release arachidonic acid in contrast with venom phospholipases A2. (1994) (46)
- Histamine and leukotriene‐independent guinea‐pig anaphylactic shock unaccounted for by Paf‐acether (1985) (44)
- Inhibition by sulphinpyrazone of the platelet-dependent bronchoconstriction due to platelet-activating factor (PAF-acether) in the guinea pig. (1981) (43)
- Protective Effect of Estradiol on Acute Lung Inflammation Induced by an Intestinal Ischemic Insult is Dependent on Nitric Oxide (2013) (41)
- Effects of birch pollen and traffic particulate matter on Th2 cytokines, immunoglobulin E levels and bronchial hyper‐responsiveness in mice (2002) (39)
- Mycobacterium bovis Bacillus Calmette-Guérin Killed by Extended Freeze-Drying Targets Plasmacytoid Dendritic Cells To Regulate Lung Inflammation (2009) (38)
- Persistence of bronchopulmonary hyper‐reactivity and eosinophilic lung inflammation after anti‐IL‐5 or ‐IL‐13 treatment in allergic BALB/c and IL‐4Rα knockout mice (2003) (37)
- Expression of the type-II phospholipase A2 in alveolar macrophages. Down-regulation by an inflammatory signal. (1995) (37)
- PAF-acether-induced synthesis of prostacyclin by human endothelial cells. (1986) (36)
- Constitutional Thrombocytopathy with Subnormal Response to Thromboxane A2 (1981) (35)
- INHIBITION BY NON‐STEROID ANTI‐INFLAMMATORY AGENTS OF RABBIT AORTA CONTRACTING ACTIVITY GENERATED IN BLOOD BY SLOW REACTING SUBSTANCE C (1974) (33)
- Acute hypotension due to carrageenan, arachidonic acid and slow reacting substance C in the rabbit: role of platelets and nature of pharmacological antagonism. (1977) (33)
- Interleukin-5 and eosinophil cationic protein in nasal lavages of rhinitis patients. (1995) (32)
- Upregulation by glucocorticoids of responses to eosinopoietic cytokines in bone‐marrow from normal and allergic mice (2000) (32)
- Triggering by Paf‐acether and adrenaline of cyclo‐oxygenase‐independent platelet aggregation (1984) (32)
- Suppression of immediate and late responses to antigen by a non-anaphylactogenic anti-IgE antibody in a murine model of asthma. (1999) (32)
- Dissociation of platelet activation from transmethylation of their membrane phospholipids (1981) (31)
- Convulxin-induced activation of intact and of thrombin-degranulated rabbit platelets: specific crossed desensitisation with collagen. (1983) (30)
- Immunopathologic alterations in the bronchi of immunized guinea pigs. (1993) (30)
- Demonstration of the therapeutic potential of non-anaphylactogenic anti-IgE antibodies in murine models of skin reaction, lung function and inflammation. (1997) (30)
- Convulxin-induced platelet aggregation is accompanied by a powerful activation of the phospholipase C pathway. (1994) (29)
- Familial and constitutional bleeding disorder due to platelet cyclo‐oxygenase deficiency (1983) (28)
- Role of lipoxygenase metabolites for the hyper-responsiveness to platelet-activating factor of lungs from actively sensitized guinea pigs. (1989) (27)
- Down-regulation by prostaglandins of type-II phospholipase A2 expression in guinea-pig alveolar macrophages: a possible involvement of cAMP. (1998) (27)
- Interference of bromophenacyl bromide with platelet phospholipase A2 activity induced by thrombin and by the ionophore A23187. (1980) (27)
- Relaxation of the guinea-pig trachea induced by platelet-activating factor and by serotonin. (1982) (26)
- Pharmacological evidence for a vasodilator receptor to serotonin in the nasal vessels of the dog. (1974) (26)
- Interference of the PAF-acether antagonist BN 52021 with endotoxin-induced hypotension in the guinea-pig. (1986) (26)
- Lipopolysaccharide from Escherichia coli reduces antigen-induced bronchoconstriction in actively sensitized guinea pigs. (1991) (26)
- Synthesis of thromboxane A2 by non-aggregating dog platelets challenged with arachidonic acid or with prostaglandin H2. (1977) (26)
- Interactions between granulocytes and platelets with the guinea-pig lung in passive anaphylactic shock. Correlations with PAF-acether-induced lesion. (1987) (25)
- Activation and damage of cultured airway epithelial cells by human elastase and cathepsin G. (1992) (25)
- Extended freeze‐dried Mycobacterium bovis Bacillus Calmette–Guérin induces the release of interleukin‐12 but not tumour necrosis factor‐α by alveolar macrophages, both in vitro and in vivo (2003) (25)
- Inhibition of airways inflammation by dexamethasone is followed by reduced bronchial hyperreactivity in BP2 mice (1996) (25)
- Conversion of 3H-PAF acether by rabbit platelets is independent from aggregation: evidences for a novel metabolite. (1983) (24)
- LTB4, a potent chemotactic factor for purified guinea-pig eosinophils: interference of PAF-acether antagonists. (1991) (24)
- Platelet activation by non-coagulant snake venom components. (1982) (23)
- Mycobacterium bovis BCG killed by extended freeze-drying reduces airway hyperresponsiveness in 2 animal models. (2008) (23)
- Intratracheal E. coli lipopolysaccharide induces platelet-dependent bronchial hyperreactivity. (1993) (22)
- Increased eosinophil cationic protein levels in bronchoalveolar lavage from wheezy infants (2001) (21)
- Structural requirements for preventing the aspirin- and the arachidonate-induced inactivation of platelet cyclo-oxygenase: additional evidence for distinct enzymatic sites. (1984) (21)
- Mechanisms of bronchoconstriction and of thrombocytopenia induced by collagen in the guinea pig. (1979) (21)
- ORG 6001 (3α‐amino‐5α‐androstan‐2β‐ol‐17‐one hydrochloride), a steroidal anti‐arrhythmic agent (1975) (21)
- Differential effects of prostacyclin and prostaglandin E1 on bronchoconstriction and thrombocytopenia during collagen and arachidonate infusions and anaphylactic shock in the guinea-pig. (1979) (20)
- Intravenous injections of PAF-acether induce platelet aggregation in rats. (1988) (20)
- Phospholipase A2‐mediated release of arachidonic acid in stimulated guinea pig alveolar macrophages: Interaction with lipid mediators and cyclic AMP (1989) (20)
- Platelet desensitization induced by arachidonic acid is not due to cyclo‐oxygenase inactivation and involves the endoperoxide receptor (1985) (19)
- Modulation of the bronchial inflammation in sensitized guinea-pigs by FK506, nedocromil sodium and dexamethasone. (1995) (18)
- Effects of PAF-acether and structural analogues on platelet activation and bronchoconstriction in guinea-pigs. (1986) (18)
- What can we learn from murine models of asthma? (1999) (18)
- Synthesis of thromboxane B2 in incubates of dog platelet-rich plasma with arachidonic acid and its inhibition by different drugs. (1978) (18)
- Interference of eicosapentaenoic and docosahexaenoic acids with arachidonate-and U46619-induced platelet activation and desensitization. (1988) (18)
- Alveolar macrophages and eicosanoids but not neutrophils, mediate bronchoconstriction induced by FMLP in the guinea‐pig (1989) (17)
- Proceedings: Role of platelet aggregation in bronchoconstriction in guinea-pigs. (1975) (17)
- Thromboxane A2 accounts for bronchoconstriction but not for platelet sequestration and microvascular albumin exchanges induced by fMLP in the guinea pig lung. (1992) (16)
- L8027 and 1-nonyl-imidazole as non-selective inhibitors of thromboxane synthesis. (1979) (15)
- Antagonism by anti-inflammatory drugs of tissue slow reacting substance C (1970) (14)
- The role of Ca2+ in regulating the catabolism of PAF-acether (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) in rabbit platelets. (1987) (14)
- Blockade of the inflammatory effects of platelet-activating factor by cyclo-oxygenase inhibitors. (1981) (13)
- From anti-asthma drugs to PAF-acether antagonism and back. Present status. (1989) (13)
- Role of the metabolites of arachidonate in platelet-dependent and independent experimental bronchoconstriction. (1981) (13)
- Inhibition by pulmonary surfactant Curosurf of secretory phospholipase A2 expression in guinea-pig alveolar macrophages. (1997) (13)
- Cellular source of human platelet secretory phospholipase A2 (1998) (12)
- Inhibition by nedocromil sodium of recombinant human interleukin-5-induced lung hyperresponsiveness to platelet-activating factor in actively sensitized guinea pigs. (1993) (12)
- Inhibition of phospholipase A2 activity in guinea pig eosinophils by human recombinant IL-1 beta. (1992) (11)
- Platelet-lung in vivo interactions: an artifact of a multi-purpose model? (1979) (11)
- Pharmacological modulation of the respiratory and haematological changes accompanying active anaphylaxis in the guinea-pig. (1986) (11)
- Dissociation between the phospholipases C and A2 activities in stimulated platelets and their involvement in the arachidonic acid liberation (1994) (11)
- Strain‐dependency of leukotriene C4 generation from isolated lungs of immunized mice (1994) (11)
- Interference of anti‐inflammatory and anti‐asthmatic drugs with neutrophil‐mediated platelet activation: singularity of azelastine (1991) (11)
- Platelet Aggregation Study in Migraine Patients between and during Attacks (1985) (10)
- 3 Deazaadenosine and L-homocysteine inhibit platelet aggregation induced by collagen and convulxin through a phospholipase A2 independent mechanism. (1982) (10)
- Formation of LTB4 by fMLP‐stimulated alveolar macrophages accounts for eosinophil migration in vitro (1992) (10)
- Interference of transmethylation inhibitors with thromboxane synthesis in rat platelets. (1982) (10)
- Fenspiride: an anti-inflammatory drug with potential benefits in the treatment of endotoxemia. (1995) (10)
- Effects of nedocromil sodium on antigen-induced conjunctivitis in guinea pigs (2000) (9)
- Enhancement by prostacyclin of the contractility of the guinea-pig airways smooth muscle. (1981) (9)
- PAF-Acether May Not Mediate the Third Pathway of Platelet Aggregation since Self-Desensitization Reduces the Effects of Low Thrombin but Enhances Those of Convulxin (1985) (9)
- Competitive inhibition of phospholipase A2 activity by the platelet-activating factor antagonist Ro 19-3704 and evidence for a novel suppressive effect on platelet activation. (1993) (9)
- Role of eosinophilic airway inflammation in models of asthma. (1997) (8)
- LOCAL ANAESTHETIC AND ANTIARRHYTHMIC PROPERTIES OF AN AMINOSTEROID: 3α‐DIMETHYL‐AMINO‐5α‐ANDROSTAN‐2β‐OL‐17‐ONE (ORG. NA13) (1975) (8)
- Selective inhibition of adrenaline‐induced human platelet aggregation by the structurally related Paf antagonist Ro 19–3704 (1989) (8)
- Pharmacological modulation of 2‐methyl‐carbamate‐PAF induced rat paw oedema (1990) (8)
- Involvement of leukotrienes in allergic inflammation in mice. (1994) (8)
- Is tartrazine-induced asthma related to inhibition of prostaglandin biosynthesis? (1980) (8)
- Degranulation of Rabbit Platelets with PAF-Acether: A New Procedure for Unravelling the Mode of Action of Platelet-Activating Substances (1982) (8)
- 5-Lipoxygenase and endotoxin-induced microvascular albumin exchanges and leucocyte recruitment in guinea-pig lungs. (1997) (7)
- Platelet-activating factor (PAF-acether) (1982) (7)
- Clostridiopeptidase B inhibition by plasma marcroglobulins and microbial antiproteases. (1978) (7)
- Animal Models for Investigating the Allergic and Inflammatory Properties of Platelets (1995) (7)
- Ectopic lung transplantation induces the accumulation of eosinophil progenitors in the recipients' lungs through an allergen‐ and interleukin‐5‐dependent mechanism (2007) (7)
- Reversible inhibition by protamine of human synovial and rabbit platelet secretory phospholipase A2. (1996) (6)
- Reduction by arachidonic acid of prostaglandin I2-induced cyclic AMP formation. Involvement of prostaglandins E2 and F2 alpha. (1993) (6)
- PAF-acether and experimental anaphylaxis as a model for asthma. (1989) (6)
- Expression of the Type-II Phospholipase A in Alveolar Macrophages (1995) (5)
- Dissociation between LPS-induced bronchial hyperreactivity and airway edema in the guinea-pig (1991) (5)
- Inhibition by metal-chelating agents and by catalase of arachidonic acid-induced platelet aggregation. (1976) (5)
- Comparison between the antiaggregating effect of ticlopidine in whole blood, platelet-rich plasma and washed platelets of the rat. (1982) (5)
- Carrageenan‐induced activation of human platelets is independent of phospholipase A2 and of formation of thromboxanes (1980) (5)
- The pharmacology of slow reacting substance C and of arachidonic acid (2005) (5)
- Cytokines and adhesion molecules in lung inflammation (1996) (5)
- Platelet effects of arachidonic acid in dog blood. II. Involvement of cyclo-oxygenase in the in vitro situation. (1977) (5)
- Modulation by cyclic AMP of arachidonic acid-induced platelet desensitization. (1986) (5)
- Blockade by methylation inhibitors of the anaphylactic response of guinea‐pig lung strips (1987) (5)
- Effect of active sensitization on the bronchopulmonary responses to tachykinins in the guinea pig. Modulation by peptidase inhibitors. (1993) (5)
- Desensitization and antagonism of rat polymorphonuclear leukocytes stimulated with PAF acether. (1987) (5)
- Cell-associated and soluble phospholipases A2 increase during carrageenan and zymosan-induced pleurisy in rat (1993) (4)
- PAF-acether autogenerated in the guinea-pig arterial wall may account for local thromboformation (1988) (4)
- Pertussis toxin induces bronchopulmonary hyperresponsiveness in guinea-pigs while antagonizing the effects of formyl-L-methionyl-L-leucyl-L-phenylalanine. (1992) (4)
- Mechanism of clostripain-induced kinin release from human, rat and canine plasma (1976) (4)
- Platelet-tissue interaction: Role of platelet-activating factor (PAF-acether) (1980) (4)
- Salicylic acid prevents inhibition by aspirin of arachidonic acid-induced hypotension, bronchoconstriction and thrombocytopenia [proceedings]. (1977) (4)
- γ‐Thrombin‐induced phospholipase A2 activation in rabbit platelets: Comparison with α‐thrombin (1989) (4)
- Trends in inflammation research I: edited by G.P. Velo, Birkhäuser Verlag, 1980. SFr. 122 (x + 326 pages) ISBN 3 7643 1177 0 (1982) (4)
- Platelet effects of arachidonic acid in dog blood. I. Lack of involvement of cyclo-oxygenase in the in vivo situation. (1977) (4)
- Albumin exchange and inflammatory cell recruitment in lungs of antigen-challenged guinea pigs: role of histamine. (1994) (4)
- Interference of Anti-Inflammatory Drugs with Hypotension (1979) (4)
- Platelets Release a New Mediator, Platelet-Activating Factor, Which Accounts for ADP and Thromboxane-Independent Aggregation (1979) (4)
- The pharmacology of slow reacting substance C and of arachidonic acid (1973) (3)
- Inhibition by azelastine of the effects of platelet-activating factor in lungs from actively sensitised guinea-pigs. (1992) (3)
- Antagonists of PAF-acether do not suppress thrombin-induced aggregation of ADP-deprived and aspirin-treated human platelets (1987) (3)
- Do leukotrienes account for antigen-induced bronchoconstriction in the guinea-pig? (1985) (3)
- Characterization of a thrombopathy (type delta storage pool disease) affecting a pig colony. (1992) (3)
- [Platelet aggregation and platelet activating factor (author's transl)]. (1980) (3)
- Methylation Inhibitors Impair Collagen-Induced Activation of Human Platelets (1983) (3)
- Carrageenan‐induced activation of human platelets is dependent on the phospholipase C Pathway (1993) (3)
- Substances that increase the cyclic AMP content prevent platelet aggregation and the concurrent release of pharmacologically active substances evoked by arachidonic acid (1975) (3)
- Azelastine potentiates the prostaglandin-induced increase of cyclic AMP content in human platelets and in guinea-pig alveolar macrophages. (1992) (3)
- Interference of the thromboxane antagonist SK&F 88046 with platelet activation and subsequent desensitization by arachidonic acid and the thromboxane mimetics U46619 and EP171. (1987) (3)
- Bronchopulmonary Pharmacology of PAF-Acether (1987) (3)
- Immunization Induces Bronchopulmonary Hyperresponsiveness and Increased Mediator Release from Guinea Pig Lungs Role of Lipoxygenase Derivatives (1988) (3)
- Is Phospholipase A2 (PLA2) Involved In PAF-Acether Formation By Platelets (1981) (2)
- Immunohistochemical characterization of T lymphocytes and eosinophils in the bronchial wall of actively sensitized guinea pigs. (1993) (2)
- Pharmacological modulation of PAF-acether-induced pleuresy in rats and its relevance for inflammation by zymosan (1988) (2)
- Booster-Dependent Alterations of the Subsets of T Lymphocytes and Eosinophils in the Bronchi of Immunized Guinea Pigs. (1992) (2)
- Comparison of the eosinophilotactic effect of PAF-acether and antigen in vivo: role of PAF-acther antagonist and platelets (1987) (2)
- Effect of PAF-acether antagonists, RP 48740 and BN 52021, on platelet activation and bronchoconstruction induced by PAF-acether and structural analogues in guinea-pig (1985) (2)
- Dissociation between inhibition of phospholipid methylation and production of PAF-acether by rabbit platelets (1984) (2)
- Therapeutic Administration of Mycobacterium bovis BCG Killed by Extended Freeze-Drying Modulates Airway Inflammation in a Chronic Murine Model of Asthma (2013) (2)
- The Role of Thrombocytes in Inflammation (1982) (2)
- Interactions Between Dipyridamole and Prostaglandin E1 with ADP-Induced Aggregation of Rat Platelet in Whole Blood (1984) (2)
- Emergence of T-lymphocytes, eosinophils and dendritic cells in the bronchi of actively sensitized guinea pigs after antigenic challenge. (1994) (2)
- Modulation by IL-10 of antigen-induced allergic responses in mice. (1997) (2)
- Meeting on whether there is a case for platelet activating factor acether antagonists paris france june 21 1985 (1985) (2)
- Specificity of the pharmacological inhibition of PAF-acether induced stimulation of rats polymorphonuclear leukocytes (1985) (2)
- Chronic obstructive pulmonary disease: an old disease with novel concepts and drug strategies. (2001) (2)
- Release of platelet-activating factor (PAF-acether) and arachidonic acid metabolites from alveolar macrophages (1981) (2)
- Interference of dexamethasone with leukocyte blood volume and albumin movements in lungs from endotoxemic guinea-pigs. (1995) (1)
- PAF-acether in the carrageenan-induced inflammatory reaction in mice (1988) (1)
- Correlations between eosionophils and bronchopulmonary hyperreactivity in animal models: role of cytokines by hyper-IgE mice (1998) (1)
- Leukotrienes C and D induce aspirin-sensitive bronchoconstriction in the guinea-pig. (1981) (1)
- Pharmacological properties of PAF-acether in the guinea-pig: Platelet-dependent and independent reactions (1982) (1)
- The Role of Biologically Active Lipids in Platelet Aggregation (1979) (1)
- [Demonstration of the immunoreactivity of polynuclear eosinophils for bombesin and substance P. A new concept of the neuro-immune axis]. (1996) (1)
- [Platelet aggregation and PAF-acether. Pharmacologic interference]. (1984) (1)
- Why do some beta adrenergic agonists inhibit generation of thromboxane A2 in incubates of platelets with arachidonic acid? (1978) (1)
- Adrenaline/PAF acether synergism on human platelets: involvement of Hydergine. (1985) (1)
- Lymphatic System Influence On Acute Lung Injury After Intestinal Ischemia/reperfusion In Female Rats (2014) (1)
- Phospholipids, particularly platelet-activating factor (PAF-acether), in experimental bronchoconstriction. (1983) (1)
- [Role of lipid mediators in allergic reactions]. (1991) (1)
- Interference of the PAF-acether antagonist Ro 19–3704 with PAF-acether and FMLP-induced superoxide anion and thromboxane B2 generation by guinea-pig alveolar macrophages and rabbit neutrophils (1988) (1)
- Interference of PAF-acether antagonists with the hyperresponsiveness to PAF-acether of lungs from actively sensitized guinea-pigs (1988) (1)
- Involvement of mediators in the interaction of platelets and carrageenan. (1977) (1)
- Is platelet-activating factor involved in bronchopulmonary hyperresponsiveness? (1992) (1)
- Interference of transmethylation inhibitors with thromboxane synthesis in rat platelets: evidence for the requirement of a methyl transfer reaction in platelet activation. (1983) (1)
- [THE USE OF ANTAZOLINE IN THE TREATMENT OF CARDIAC ARRHYTMIAS. CLINICAL STUDY]. (1964) (1)
- Mechanisms of platelet activation: role of methylation reactions (1984) (1)
- Potentiation and inhibition by clonidine of PAF-acether-induced human platelet activation. (1987) (1)
- Synergized activation of human platelets by epinephrine and platelet-activating factor-acether is adenosine diphosphate and thromboxane A2-independent. (1983) (1)
- Interactions between cyclic AMP stimulating drugs and PAF-acether in guinea-pig alveolar macrophages (2005) (1)
- Sequestration into the Murine Lungs Formation and Neutrophil α from TNF-Bronchopulmonary Hyperreactivity Dissociated Systemic Administration of Endotoxin Induces (1998) (1)
- Gamma-thrombin-induced phospholipase A2 activation in rabbit platelets: comparison with alpha-thrombin. (1989) (1)
- Inhibition by azelastine of in vitro lung hyperreactivity in the guinea pig (1990) (1)
- Platelet-activating factor (PAF-acether): Thromboxane-independent synergism with adrenaline on human platelets and recent insights into its mode of action (1982) (1)
- Arachidonate-mediated bronchoconstriction and platelet activation are inhibited by microgram doses of compound L8027 which are not selective for thromboxane synthetase. (1979) (1)
- Cell-associated and soluble phospholipases A2 increase during carrageenan and zymosan-induced pleurisy in rat. (1993) (1)
- Éosinophile et PAF-acether (1990) (0)
- Morphological and Pharmacological Evidences for the Participation of PAF-Acether in Anaphylactic Shock in the Guinea-Pig (1987) (0)
- A pharmacological analysis of imflammation induced by carrageenan and platelet-activating factor in the mice (1990) (0)
- Comparative pharmacology of arachidonic acid in various animal species: Platelet-mediated and platelet-independent reactions (2005) (0)
- In vivo and in vitro effects of carrageenan on rabbit platelets: patterns of drug inhibition [proceedings]. (1978) (0)
- Interference of estradiol on the leukocyte mobilization and expression of ICAM-1 in the lung of rat subjected to intestinal ischemia/reperfusion (2013) (0)
- Convulxin, An ADP And Thromboxane-Independent Platelet activating Glycoprotein From The Venom Of Crotalus Durissus Cascavella (1981) (0)
- Characterization of Murine Lung Inflammation after Infection with Parental Bordetella pertussis and Mutants Deficient in Adhesins or Toxins (1994) (0)
- Platelet activating factor acether is involved in thrombin-induced synthesis of prostacyclin by human endothelial cells. (1987) (0)
- New vistas on the role of platelets in bronchoconstrictions. (1979) (0)
- Mechanisms of collagen-induced bronchoconstriction and thrombocytopenia in the guinea-pig [proceedings]. (1978) (0)
- Activation of phospholipase A2 in experimental pleuresy (1990) (0)
- Familial And Constitutional Moderate Bleeding Disorder Associated With Defective Platelet Cyclo-Oxygenase (1981) (0)
- Mechanisms ofcollagen-induced bronchoconstriction andthrombo- cytopenia intheguinea-pig (1978) (0)
- 1070 – PLATELETS AND PROSTAGLANDINS (1978) (0)
- Contents, Vol. 66, Supplement 1, 1981 (1981) (0)
- Indirect release of kinin-like activity by clostripain (1976) (0)
- Aspects of release of pharmacologically active substances from the lungs by chemical stimuli (1976) (0)
- 010 Mycobacterium bovis BCG inactivated by extended freeze-drying (EFD) controls experimental asthma via plasmacytoid dendritic cells promoting regulatory T cells (2007) (0)
- InflammationCells To Regulate Lung Freeze-Drying Targets Plasmacytoid Calmette-Guérin Killed by Extended Bacillus (2010) (0)
- PAF-acether in immediate pulmonary hypersensitivity (1987) (0)
- Lung responsiveness to antigen in sensitised mice of different strains (2005) (0)
- Contents, Vol. 92, 1990 (1990) (0)
- Metabolism of paf acether platelet activating factor and its 2 methoxycarbamate and 2 methylcarbamate analogs impact on bronchoconstriction in the guinea pig (1984) (0)
- Passive sensitization of guinea-pig lung mast cells and alveolar macrophages with anti-ovalbumin IgG1 and IgG2 antibodies (1992) (0)
- Involvement of leukotrienes and PAF-acether in the increased microvascular permeability of the rabbit retina (1984) (0)
- Synergism Between PAF-Acether and IL-5: Relevance for Eosinophil Attraction and Activation (1993) (0)
- Selective synthesis of a secretory phospholipase A2 during adherence of guinea-pig alveolar macrophages (1994) (0)
- Bronchopulmonary hyperreactivity, inflammation and mucosal metaplasia in a murine model of asthma (1998) (0)
- Impaired IL4-dependent peripheral and pulmonary Th2 responses in ovalbumin-immunized γδ T-cell-deficient mice (1998) (0)
- Experimental Lung Hyperreactivity: Pharmacological Control and Possible Role of Cytokines (1993) (0)
- Pharmacological modulation ofPaf-induced rat pleurisy andits role ininflammation byzymosan (1989) (0)
- Constitutional Thrombocytopathia with Abnormal Aggregation Different from Storage-Pool Disease and Aspirin-Like Syndrome (1977) (0)
- Bronchial Asthma and Airway inflammation (2014) (0)
- Prostaglandin E2 and salbutamol are less effective in raising cAMP levels of alveolar macrophages from ovalbumin-sensitized guinea-pigs as compared to controls (2005) (0)
- Modulation of experimental bronchopulmonary allergy by anti-inflammatory compounds (2000) (0)
- Contents, Vol. 99, 1992 (1992) (0)
- An alternative point of view on experimental lung hyperreactivity. (1990) (0)
- A new topic in ‘agents and actions’ (1979) (0)
- Interference Of Sulphynpyrazone With The Platelet And Bronchial Effects Of “Platelet-Activating Factor” (1981) (0)
- Effect of PAF-acether and endotoxin on rat mesenteric microvessels; inhibition by specific antagonists (1988) (0)
- Neutrophils induce platelet activation in rabbit and human: A role for PAF-acether only in rabbit (1988) (0)
- Biochemical mediators involved in the inflammatory reaction. Protective activity of S 5682. (1988) (0)
- Endotoxin induces bronchial hyper-resporasiveness in the guinea-pig which may involve platelets (1990) (0)
- Comparative pharmacology of arachidonic acid in various animal species: platelet-mediated and platelet-indipendent reactions [proceedings]. (1978) (0)
- Pertussis toxin modulates the bronchopulmonary responses of the guinea-pig (1990) (0)
- Enhancement of the phospholipase A2 activity in fMLP-treated guinea-pig alveolar macrophages (2005) (0)
- Leukocyte migration induced by intestinal ischemia and reperfusion in obese mice (2013) (0)
- Thromboxane-Dependent Platelet Aggregation: Role and Limitations (1981) (0)
- Utilization of primary cultures of guinea-pig respiratory epithelium to study the mode of action of anti-inflammatory drugs and prostanoids (1990) (0)
- Platelets and inflammation. (1977) (0)
- In vivo and in vitro effects of carrageenan on rabbit platelets: Patterns of drug inhibition (2005) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Boris B. Vargaftig?
Boris B. Vargaftig is affiliated with the following schools:
